Stimuli-sensitive nano-drug delivery with programmable size changes to enhance accumulation of therapeutic agents in tumors
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Nano-based drug delivery systems hold significant promise for cancer therapies. Presently, the poor accumulation of drug-carrying nanoparticles in tumors has limited their success. In this study, based on a combination of the paradigms of intravascular and extravascular drug release, an efficient nanosized drug delivery system with programmable size changes is introduced. Drug-loaded smaller nanoparticles (secondary nanoparticles), which are loaded inside larger nanoparticles (primary nanoparticles), are released within the microvascular network due to temperature field resulting from focused ultrasound. This leads to the scale of the drug delivery system decreasing by 7.5 to 150 times. Subsequently, smaller nanoparticles enter the tissue at high transvascular rates and achieve higher accumulation, leading to higher penetration depths. In response to the acidic pH of tumor microenvironment (according to the distribution of oxygen), they begin to release the drug doxorubicin at very slow rates (i.e., sustained release). To predict the performance and distribution of therapeutic agents, a semi-realistic microvascular network is first generated based on a sprouting angiogenesis model and the transport of therapeutic agents is then investigated based on a developed multi-compartment model. The results show that reducing the size of the primary and secondary nanoparticles can lead to higher cell death rate. In addition, tumor growth can be inhibited for a longer time by enhancing the bioavailability of the drug in the extracellular space. The proposed drug delivery system can be very promising in clinical applications. Furthermore, the proposed mathematical model is applicable to broader applications to predict the performance of drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732 · cited 1×
“Recently, transport through transcellular channels or via endocytosis/transcytosis has been recognized as the dominant mechanism for nanoparticle extravasation (Sindhwani et al., 2020).”
BackgroundChauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101
Duan, X., & Li, Y. (2013) · Small · doi:10.1002/smll.201201390 · Cited by 926
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Yong, T., Zhang, X., Bie, N., Zhang, H., Zhang, X., Li, F., Hakeem, A., Hu, J., Gan, L., Santos, H. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11718-4 · Cited by 806 · cited 1×
“In addition, the current model confirms the results of previous research (Yong et al., 2019; gao et al., 2011; Xiong et al., 2020) on sustained release, demonstrating that it reduces tumor growth rate over a long period of time.”
ResultEngineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Self-citationRole of vascular normalization in benefit from metronomic chemotherapy
Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700340114 · Cited by 178 · cited 1×
“This causes the penetration depth and concentration of the free drug, followed by the internalized drug, to be greater. on experimental results (Andriyanov et al., 2014; Mpekris et al., 2017; Igarashi et al., 2021; Mpekris et al., 2022).”
ResultTowards principled design of cancer nanomedicine to accelerate clinical translation
Souri, M., Soltani, M., Moradi Kashkooli, F., Kiani Shahvandi, M., Chiani, M., Shariati, F. S., Mehrabi, M. R., & Munn, L. L. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100208 · Cited by 159
Self-citationA reanalysis of nanoparticle tumor delivery using classical pharmacokinetic metrics
Price, L. S. L., Stern, S. T., Deal, A. M., Kabanov, A. V., & Zamboni, W. C. (2020) · Science Advances · doi:10.1126/sciadv.aay9249 · Cited by 128 · cited 1×
“…tumor penetration; hyperthermia; multi-stage delivery system; focused ultrasound; temperature-sensitive nanoparticles; pH-responsive nanoparticles specific transvascular mechanism, have shown that the accumulation of particles in the tissue is very poor (Dai et al., 2018; Price et al., 2020).”
BackgroundNexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120 · cited 12×
“Nanoparticles with smaller sizes (less than 10 nm) compared to vascular pores and extracellular matrix pores have higher accumulation and penetration depth than their larger counterparts (Jain & Stylianopoulos, 2010; Souri, Soltani, Kashkooli, Shahvandi, 2022).”
MethodSelf-citationEnhancing Clinical Translation of Cancer Using Nanoinformatics
Soltani, M., Moradi Kashkooli, F., Souri, M., Zare Harofte, S., Harati, T., Khadem, A., Haeri Pour, M., & Raahemifar, K. (2021) · Cancers · doi:10.3390/cancers13102481 · Cited by 82
Self-citation
Cited by
Sabit, H., Pawlik, T. M., Radwan, F., Abdel-Hakeem, M., Abdel-Ghany, S., Wadan, A.-H. S., Elzawahri, M., El-Hashash, A., & Arneth, B. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02357-z · Cited by 239
Hosseinpour, A., Soltani, M., & Souri, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-52003-9 · Cited by 53
“(5): • Free drug distribution in extracellular space: Transport of the free drug released from MNPs in the inter-stitium and bound drug which is the drug that bonds to proteins in the interstitium, is governed by the CDR equations 29,30 .”
BackgroundSelf-citationKiani Shahvandi, M., Souri, M., Tavasoli, S., Moradi Kashkooli, F., Kar, S., & Soltani, M. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107574 · Cited by 37
Self-citationIntratumoral implantable drug delivery system for targeted localized chemotherapy in breast cancer
Souri, M., Elahi, S., & Soltani, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105519 · Cited by 31
Self-citationSouri, M., Elahi, S., & Soltani, M. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2323211 · Cited by 28
Self-citation
Metadata
- Authors
- Souri, M., Kiani Shahvandi, M., Chiani, M., Moradi Kashkooli, F., Farhangi, A., Mehrabi, M. R., Rahmim, A., Savage, V. M., & Soltani, M.
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2023-03-09
- Volume
- 30
- Issue
- 1
- Pages
- 2186312-2186312
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W4323808406
- Cited by
- 47
- References
- 13
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stimuli-sensitive nano-drug delivery with programmable size changes to enhance accumulation of therapeutic agents in tumors. https://app.cochat.ai/papers/10.1080/10717544.2023.2186312
- The paper
- Souri, M., Kiani Shahvandi, M., Chiani, M., Moradi Kashkooli, F., Farhangi, A., Mehrabi, M. R., Rahmim, A., Savage, V. M., & Soltani, M. (2023). Stimuli-sensitive nano-drug delivery with programmable size changes to enhance accumulation of therapeutic agents in tumors. Drug Delivery. https://doi.org/10.1080/10717544.2023.2186312
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.